Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potential
Summary
Shares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Analysts cited strong ...
Description
Shares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Analysts cited strong ...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source